Paper published (16 Feb 2022) by Dept. of Health #Australia about utilisation of antimicrobials used to treat bacterial pneumonia in principal referral hospitals during the COVID-19 pandemic in 2020 beg some serious question.
The paper mentions:-
"Overall usage (in 2020) of doxycycline, azithromycin, amoxicillin and cefuroxime decreased in principal referral hospitals compared to 2019." in #Australia
Please note, to treat bacterial pneumonia, you need doxycycline or azithromycin.
Antibacterials usage to treat community-acquired pneumonia in 2020 was not same as 2019
"In the non-critical-care setting, usage of oral amoxicillin and of oral azithromycin for the July to December period fell, on average, by 21.1% and 23.7% respectively between 2019 and 2020."
The paper mentions that data submitted to National Antimicrobial Utilisation Surveillance Program (NAUSP) in #Australia reflects dispensing and/or distribution, not actual consumption.
Hospitals were perhaps stocking up (Mar/April 2020) anticipating demand.
Paper also mentions that pandemic related interventions may have unintended benefits on non SARS-CoV-2 infections rates such as community-acquired pneumonia (CAP) - Can this be true?
Lab confirmed influenza was 8 times lower that the five-year avg.
A different report published by Dept. of Health #Australia about Antimicrobial use in Australian Hospitals during 2020 compared to 2019 which mentions that the total annual use of the macrolides (including azithromycin) fell across Australia (15.5% decline).
A very interesting entry in the report:-
"The reduction in hospital usage of antibacterials commonly used to treat community-acquired pneumonia, such as doxycycline and azithromycin, may be due to a reduction in the number of pneumonia cases in 2020."
So, if Lab confirmed influenza was all time low AND there was reduction in community-acquired pneumonia (CAP) then what happened in 2020 in #Australia ? What caused so many deaths?
Dept. of Health Australia has updated their Guidance on Myocarditis and Pericarditis after COVID-19 vaccines on 12 January 2024.
Here are some interesting points 👇🏽
#Australia
#CovidVaccines
In the guidance published on 9 Nov 2022, they said that a small number of cases of have been reported in the clinical trial and in Australia. Now, they are saying that Myocarditis and/or pericarditis can occur after Novavax at a similar rate to the mRNA vaccine.
Myocarditis - 4 in every 100K doses.
Pericarditis - 13 in every 100K doses.
The Office of Gene Technology Regulator (OGTR), which is part of Dept. of health #Australia is crying 'misinformation' because .@SenatorRennick & .@Jikkyleaks called them out on their BS on mRNA vaccines and 'transfection'.
Those who are not aware, please refer to this iconic thread shared by .@Jikkyleaks where .@SenatorRennick questioned Dr Raj Bhula who is the current Regulator (OGTR) and has over 20 years’ experience in the regulation of pesticides in Australia.
Their statement reads:
'transfect' - It 'may' also mean ‘enter into the cell’s
nucleus to stably integrate in the genome’. This is a meaning that DOES NOT apply to the two mRNA vaccine.
How can they say it, as @Jikkyleaks pointed out so rightly 👇🏽
The notes from the Australian senate committee supplementary budget estimates 2021- 2022 on #Ivermectin are stunning.
A 🧵
#Ivermectin
#Australia
One of the key reason to restrict prescribing #Ivermectin was that people would have taken ivermectin to treat or prevent COVID-19 infection rather than getting vaccinated.
#Australia
Did you know that the decision to restrict prescribing of #ivermectin was not open to public consultation.
The risk they are highlighting which is spreading of COVID-19 in the community.
Please note that that COVID-19 vaccine never prevented transmission.
In late 2022, as part of the process of should the restriction on #Ivermectin be lifted in Australia, The NSW Poisons Information centre (NSW PIC) in their submission to the TGA advised that they were not in favor.
#Ivermectin
#Australia
This is because since restriction was applied, they had 35 calls regarding exposures to ivermectin which was being inappropriately used for Covid treatment or prevention.
#Ivermectin
#Australia
How the use of vet products indicated the restrictions (of ivermectin) in prescribing working?
The restriction forced people to obtain #Ivermectin illegally or to use ivermectin manufactured for animals. The prohibition produced the opposite desired impact.
In Jan 2021, when TGA "Provisionally" approved ASTRAZENECA COVID-19 vaccine, they knew the following:-
1. Bio-distribution study was pending. 2. Vaccine long term immunity was a concern & not assessed. 3. Booster didn't provide better protection. https://t.co/DEKZ6Uusuqtwitter.com/i/web/status/1…
4. Did you know there were concerns for Anti-ChAd vector antibodies due to repeat vaccination?
On 9 Feb 2022, TGA #Australia provisionally approved AstraZeneca's COVID-19 vaccine as booster dose.
6. This report was authorized on 28 Jan 2021.
They knew that Antibodies generally declined quickly over 2 weeks after the booster dose and yet on 9 Feb 2022 (an year later), TGA "provisionally" approved AstraZeneca's COVID-19 vaccine as booster dose.
This email exchange from January 2021 b/w Prof. Allen Cheng (ATAGI Voting member) and Prof. Paul Kelly (Australia Chief Medical Officer) is intriguing.
“Why would we use a vaccine that mightn't prevent transmission?"
🤡👉🏽🌏
I am quite not sure what "herd immunity" Prof. Cheng is talking about with COVID-19 vaccines as these vaccines do no prevent one from contracting it and does not prevent trasmission.
#Australia
Professor Paul Kelly's responded advising to add - "This is not the end of the vaccine story, it’s the beginning. We don’t know how long protection will last for any of the vaccine candidates, so we may need to revaccinate"